Correction: Case Report: PD-1/CTLA-4 dual checkpoint blockade(QL1706) in advanced pulmonary squamous cell carcinoma complicated by multidrug-resistant tuberculosis after multiple lines of immunotherapy - Top-Institutions - MDSpire

Correction: Case Report: PD-1/CTLA-4 dual checkpoint blockade(QL1706) in advanced pulmonary squamous cell carcinoma complicated by multidrug-resistant tuberculosis after multiple lines of immunotherapy

  • By

  • Li Huang

  • Hao Li

  • June 11, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    Dana-Farber Cancer Institute
    Dana-Farber Cancer Institute

    Boston, MA

    Key Differentiators

    • Oncology

  • #2

    Lowe Center for Thoracic Oncology
    Lowe Center for Thoracic Oncology

    Boston, MA

    Key Differentiators

    • Oncology

  • #3

    Yale Cancer Center
    Yale Cancer Center

    New Haven, CT

    Key Differentiators

    • Oncology

  • #4

    Alliance A091802
    Alliance A091802

    N/A, N/A

    Key Differentiators

    • Oncology

  • #5

    Yale School of Medicine
    Yale School of Medicine

    New Haven, CT

    Key Differentiators

    • Oncology

Original Source(s)

Correction: Case Report: PD-1/CTLA-4 dual checkpoint blockade(QL1706) in advanced pulmonary squamous cell carcinoma complicated by multidrug-resistant tuberculosis after multiple lines of immunotherapy

  • by Li Huang, Hao Li

  • June 11, 2026

Related Content

Radiotherapy plus immunotherapy with or without chemotherapy improves survival in elderly esophageal squamous cell carcinoma: a real-world comorbidity-stratified study

Case Report: Cutaneous niche-restricted malignant phenotypes in PTCL-NOS revealed by single-cell sequencing

Ultraviolet radiation as a double-edged regulator of melanocyte function in vitiligo therapy and melanoma carcinogenesis